Status:

Red

Decision Date:

July 2022

Comments

NICE TA1045: Acarizax (12 SQ-HDM SLIT) for treating allergic rhinitis caused by house dust mites (decision date April 2025)

For use in specialist paediatric clinic only, in accordance with local protocol. See JAPC SLIT guidance 

Red Drug Classifications

• 1: Requiring specialist assessment to enable patient selection, initiation and ongoing treating
• 2: Requiring long term on-going monitoring of efficacy by a specialist and not suitable for shared care

search again